Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chitobine is a New Jersey-based biotechnology company specializing in the production and supply of high-quality chitosan, a versatile biopolymer derived from crustacean shells. Founded by Pinal Patel, the company focuses on establishing a reliable domestic supply of chitosan for the North American market, serving industries such as agriculture, food, and cosmetics. Chitobine is actively expanding into the life sciences sector, developing medical and pharmaceutical-grade chitosan for advanced applications in wound care, drug delivery systems, and antimicrobial coatings. By repurposing seafood waste into sustainable materials, the company aims to provide eco-friendly alternatives to synthetic plastics through collaborations with leading academic institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chitobine.